Registration of Certain Foreign Establishments Act This bill expands statutory provisions that require foreign manufacturers of drugs or medical devices for the U.S. market to register with the Food and Drug Administration. Specifically, if an establishment outside of the United States manufactures (or otherwise processes or prepares) a drug or medical device to be imported (or offered for import) into the United States, the establishment must comply with the registration requirements even if the drug or medical device in question undergoes further manufacturing at another non-U.S. establishment prior to importation into the United States.
SRES 485 is a Senate resolution honoring the late Senator Harry Mason Reid, Jr., of Nevada, who died in 2021. The resolution expresses the Senate's sorrow at his passing, extends condolences to his family, and directs the Secretary of the Senate to communicate the resolution to the House of Representatives and provide a copy to Reid's family. The Senate also adjourned in his memory as a mark of respect. This is a ceremonial tribute with no policy changes or legal effect.
SRES 484 is a ceremonial Senate resolution honoring the late Senator John "Johnny" Isakson of Georgia. It formally recognizes his 40+ years of public service, including his roles in the Georgia legislature, U.S. House, and U.S. Senate, and his reputation for bipartisan cooperation. The resolution requests the Senate Secretary communicate it to the House and send a copy to Isakson's family. As a commemorative resolution, it has no policy impact or direct effect on any individuals or programs.
PrEP Access and Coverage Act This bill requires private health insurance plans to cover prescription drugs that prevent HIV, including related screenings, diagnostic procedures, administrative fees, and clinical follow-ups, without any cost-sharing obligation for the plan holder. Further, insurance plans must not impose any preauthorization requirement for this coverage. These coverage requirements also apply to public health insurance programs, including Medicare, Medicaid, and the Children's Health Insurance Program. Additionally, the bill prohibits denying, limiting, or qualifying coverage or increasing premiums for disability insurance, long-term care insurance, or life insurance policies based on an individual taking medication for HIV prevention. The bill further requires the Department of Health and Human Services to award grants to states, or directly to eligible local organizations, to provide uninsured individuals and underinsured individuals access to prescription drugs and related services that prevent HIV. The Centers for Disease Control and Prevention also must develop a public awareness campaign that focuses efforts in communities with a high need for HIV prevention treatment.
This bill revises enforcement provisions under the Animal Welfare Act (AWA), including by directing inspectors to confiscate or destroy in a humane manner animals found to be suffering physical or psychological harm as a result of failure to comply with the AWA.
Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities for scientific research utilizing data from expanded access to investigational ALS treatments for individuals who are not otherwise eligible for clinical trials. The Food and Drug Administration (FDA) shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other rare neurodegenerative diseases. HHS shall also establish the Public-Private Partnership for Neurodegenerative Diseases between the National Institutes of Health, the FDA, and at least one eligible entity (generally, an institution of higher education or a nonprofit organization). The partnership shall support the development and regulatory review of drugs that address ALS and other rare neurodegenerative diseases. The FDA shall publish on its website a five-year action plan for fostering the development of drugs that improve or extend the lives of people living with rare neurodegenerative diseases. The Government Accountability Office must report to Congress about the grants provided under this bill, including an analysis of the impact of such grants on research and development of treatments for ALS.
Capitol Police Emergency Assistance Act of 2021 This bill allows the chief of the U.S. Capitol Police to request emergency assistance from executive departments and executive agencies to prevent significant disruption of governmental function and public order at the U.S. Capitol. The bill also eliminates statutory qualification and approval requirements for law enforcement and uniformed service personnel appointed to serve as special police officers, including during periods of emergency initiated by the chief under the bill. Further, special police regulations prescribed by the U.S. Capitol Police Board are subject to approval by the Speaker of the House and Senate majority leader under the bill. Those regulations are subject to approval by the Speaker and the President pro tempore of the Senate under current law. Finally, the bill requires the Senate Committee on Rules and Administration and the House Committee on House Administration to jointly conduct at least one oversight hearing of the U.S. Capitol Police Board during each Congress.
This resolution (1) supports the designation of National Blueberry Month; and (2) recognizes the contributions of U.S. growers and their families, and that purchasing blueberries grown in the United States supports farmers, jobs, and the economy.
The Health Coverage Tax Credit Reauthorization Act of 2021 extends the expiration date of the Health Coverage Tax Credit from January 1, 2022, to January 1, 2026. This tax credit helps individuals purchasing health insurance through the Marketplace reduce their premium costs. The extension applies to months beginning after December 31, 2021, ensuring continued support for eligible individuals through 2025.
Anti-Spoofing Penalties Modernization Act of 2021 This bill doubles the penalties for providing misleading or inaccurate caller identification information with intent to defraud, cause harm, or wrongfully obtain anything of value.
Anti-Spoofing Penalties Modernization Act of 2021 This bill doubles the penalties for providing misleading or inaccurate caller identification information with intent to defraud, cause harm, or wrongfully obtain anything of value.
This concurrent resolution expresses the sense of Congress that tax-exempt fraternal benefit societies provide critical benefits to the people and communities of the United States and their work should continue to be promoted.
